Clinical Trial Update: A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates the impact of an early biopsy in kidney transplant patients treated with mycophenolate mofetil (CellCept) and the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED